Circadian Depression Affects Nearly a Quarter of Patients
Australian researchers have identified a new subtype of depression called circadian depression
that is linked to internal body clock disruptions and resists traditional antidepressant treatments. Published in the British Journal of Psychiatry, the study analyzed clinical and genetic data from 11,380 Australians experiencing mostly severe and recurrent depression. The findings show that nearly 23 percent of the participants fit the criteria for this specific biological subtype.
The study defines the condition through six distinct features. Patients with circadian depression experience seasonal patterns of illness, delayed sleep timing, longer sleep durations during depressive episodes, evening chronotypes, morning fatigue, and social jetlag where workweek and weekend sleep schedules diverge significantly. Dr. Emiliana Tonini, the first author from the University of Sydney’s Brain and Mind Centre, stated during a press briefing that affected individuals report younger onset ages, more frequent episodes, complex trajectories, and higher rates of suicidality, hypomanic symptoms, and psychotic-like symptoms.
Genetic Markers and Poor Response to Standard Antidepressants
Participants categorized under circadian depression display higher genetic risks for ADHD, mood disorders, metabolic markers, and inflammatory markers. Dr. Tonini explained that this underlying biology separates the condition from general depression accompanied by poor sleep. Professor Ian Hickie, a psychiatrist and co-director of the Brain and Mind Centre, noted that standard first-line therapies such as SSRIs and SNRIs prove less effective and trigger more side effects for this patient group.
Independent experts evaluated the methodology and how the research affects other fields. Professor Jayashri Kulkarni, director of the Monash Alfred Psychiatry Research Centre, called it a well-conducted study that successfully connects specific depression types to polygenic risk scores. Professor Andrew Coogan, a behavioural neuroscientist at Maynooth University in Ireland, noted that while the link between major depression and body clock changes is long-established, the exploratory findings warrant further examination.
Chronobiological Treatments Target Internal Clocks
Because standard antidepressants fail to treat the circadian subtype effectively, researchers recommend shifting focus toward chronobiological interventions. Professor Hickie emphasized that therapies targeting the sleep-wake cycle—including morning light exposure, daylight activity, and strict regularity in sleep-wake and food schedules—are critical for managing the condition. Dr. Tonini added that future clinical diagnoses of circadian depression could guide tailored treatments, particularly for young people seeking mental health support for the first time.
Frequently Asked Questions About Circadian Depression
What specific criteria define circadian depression?
Researchers define the subtype by a combination of at least three out of six features: seasonal illness patterns, delayed sleep timing, sleeping longer when depressed, evening chronotype, severe morning tiredness, and social jetlag between workdays and free days.
How does circadian depression differ from standard depression?
Patients with circadian depression show distinct genetic, metabolic, and inflammatory markers alongside a younger age of onset, higher rates of suicidality, and poorer responses to standard SSRI and SNRI medications.
What treatments are recommended for this subtype?
Experts recommend chronobiological interventions rather than standard antidepressants, focusing on morning light exposure, regular sleep-wake schedules, daylight activity, and consistent mealtimes.
Related reading